This document discusses immunodeficiency disorders. It begins by defining immunity and the immune system. There are two types of immunodeficiency disorders: primary (congenital) and secondary (acquired). Primary disorders are inherited and cause susceptibility to infections from a young age. They are classified based on defects in humoral immunity, cell-mediated immunity, or both. Examples of specific primary disorders are provided for each category. Secondary immunodeficiency is caused by external factors like HIV/AIDS, which damages the immune system over time. The document outlines evaluation, characteristics, treatment and clinical manifestations of various primary and secondary immunodeficiencies.
Immunological Disorders can be classified into 3 distinct categories.They are Hypersensitivity, Autoimmunity and Immunodeficiency.Here in this presentation we talk about Immunodeficiency disorders.Get more on our blog : http://dentistryandmedicine.blogspot.com/
The presentation includes an overview of hypersensitivity and type 1 hypersensitivity with certain pictures elaborating the mechanism. The presentation also talks about asthma very briefly as an example of type 1 hypersensitivity.
Secondary Immunodeficiency
By Dr. Usama Ragab Youssif
Reference: Included in Slides
Include causes of secondary immunodeficiency including AIDS and other viral infections
Pediatric Home Service Medical Director, Dr. Roy Maynard discusses deficiencies of innate immune system and other well-defined immunodeficiency syndromes.
Immunological Disorders can be classified into 3 distinct categories.They are Hypersensitivity, Autoimmunity and Immunodeficiency.Here in this presentation we talk about Immunodeficiency disorders.Get more on our blog : http://dentistryandmedicine.blogspot.com/
The presentation includes an overview of hypersensitivity and type 1 hypersensitivity with certain pictures elaborating the mechanism. The presentation also talks about asthma very briefly as an example of type 1 hypersensitivity.
Secondary Immunodeficiency
By Dr. Usama Ragab Youssif
Reference: Included in Slides
Include causes of secondary immunodeficiency including AIDS and other viral infections
Pediatric Home Service Medical Director, Dr. Roy Maynard discusses deficiencies of innate immune system and other well-defined immunodeficiency syndromes.
Immunodeficiency is a state in which the body is incapable of of protecting it from foreign pathogens. It is classified into two categories primary - which can be inherited and secondary - which is caused due to life style factors, drugs, nutrition. Treatments include - antibiotics- to suppress the symptoms , stem transplantation- done to introduce the deficient immune cells. There are many diseases associated with immunodeficiency.
Contents- Introduction to Immunodeficiency | Types | SCID | LAD
Immunodeficiency is the inability to produce an adequate immune response because of insufficiency or absence of antibodies, immune cells or both.
SCID & LAD are the two immunodeficiencies from primary immunodeficiency.
Microbiology of Cytomegalovirus (Herpes).pptxNawangSherpa6
The Presentation here is about Medically important Cytomegalovirus. How does it infect the Human host? What are it's clinical manifestations and How can we diagnose for their infection and potential application for other studies.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
4. CLASSIFICATION
• Immunodeficiency:
• Primary or Congenital:
•
•
•
•
Inherited (due to Mutation in genes controlling immune cells)
Susceptible to recurrent, severe infection; starting in children
Cannot recover without treatment
>125 immunodeficiency disorders
• Secondary or Acquired:
• As a consequence of other diseases or environmental factors
• E.g: Infection, Malignancy, Aging, Starvation, Medication & Drugs)
• Acquired Immuno Deficiency Syndrome – Human Immunodeficiency Virus.
6. • Four Categories Immune Mechanisms
• Humoral (Antibody or B-cell mediated)
• Specific type of mechanism
• Cell-mediated (T-cell mediated)
• Specific type of mechanism
• Complement system
• Non-specific type of mechanism
• Phagocytosis
• Non-specific type of mechanism
8. DEFECTS IN HUMORAL MEDIATED
IMMUNITY
• Caused by the improper production of one or all of the
immunoglobins (antibodies)
• Results in an increased of infections from Staphylococcus,
Streptococcus, Haemophilus, and Pseudomonas.
• Humoral Immunodeficiencies include:
• Bruton’s X-Linked Agammaglobinulinemia
• Common Variable Immunodeficiency
• Selective Immunoglobin A Deficiency
9. DEFECTS IN CELL MEDIATED
IMMUNITY
• Caused by defects in T lymphocyte development (both CD4+ helper
cells and CD8+ cytotoxic killer cells)
• Symptoms are more severe than with humeral immunodeficiencies
• Children rarely survive beyond infancy or childhood
• Cell Mediated Immunodeficiency disorders include:
• DiGeorge Syndrome
• X-Linked Immunodeficiency with Hyper-IgM
10. COMBINED T-CELL AND B-CELL
IMMUNODEFICIENCIES
• Severe Combined Immunodeficiency (SCID)
• Ataxia Telangiecctasia
• Wiskott Aldrich syndrome
11. • Severe Combined Immunodeficiency (SCID)
• Caused by diverse genetic mutations resulting in the absence of
ALL immune function
• Infants with this disease lead a short life (~ 2 years) with chronic
opportunistic infections
• There is a milder form known as combined immunodeficiency
syndrome having a low, but not absent T-cell function.
12. • Ataxia Telangiectasia:
• Results from a mutation on chromosome 11
• Condition consists of worsening ataxia (lack of coordination) and
telangiectasia (dilated capillaries and arterioles) on the skin and
conjunctiva.
• Children have reduced levels of IgA, IgE, and IgG, and decreased
ratio of CD4+ helper T cells to CD8+ cells.
• Children are prone to recurrent upper and lower respiratory
infections and an increased risk of malignancy.
• Death from lymphoma is common
14. • Wiskott-Aldrich Syndrome:
• Patient has decreased IgM and elevated levels of IgA and IgE.
• T-cell dysfunction is initially mild then progressively worsens
making child susceptible to Hodgkin’s disease and lymphoma
• They are also susceptible to infections (including septicemia and
meningitis) caused by encapsulated microorganisms
• Signs and symptoms:
• eczema
• chronic infections
• low platelet counts
15. DISORDERS OF COMPLEMENT SYSTEM
• Complement system is an important part of the non-specific immune
response.
• Complement promotes chemotaxis, opsonization, and phagocytosis
of invasive pathogens, bacteriolysis, and anaphylactic reactions.
16. • Primary complement disorders are caused by genetic problems
• Deficiency of C1 to C4 are not at increased risk for infection
because alternate pathways can be activated.
• These patients are more prone to autoimmune diseases such as
Lupus Erythematosus and increased susceptibility to pyogenic
infections
• Deficiency of late complement components (C5, C6, C7, C8)
results in systemic Neisseria infections such as meningococcal
sepsis, meningitis and disseminated gonococcal infections.
17. • Abnormalities of the control proteins of the alternative pathway
(factor H, factor I, properdin) may result in recurrent infections.
• Deficiency of complement inhibitors (C1 esterase inhibitor,
carboxypeptidase N) leads to Hereditary Angioneurotic Edema
• Secondary Disorders of Complement
• Occur in persons with normal complement systems who have
rapid activation or turnover of complement components
• Can also occur with conditions where there is a decreased
production complement components such as in liver cirrhosis or
malnutrition.
18. DISORDERS OF PHAGOCYTOSIS
• Phagocytic system:
• Composed primarily of:
• Neutrophils, Eosinophils and Monocytes.
• Phagocytic cells function to migrate to site of infection, adhere to the
tissue, engulf invading material, and then digest it.
• A defect in the phagocytic system results in a decreased number of
phagocytic cells.
• Persons are prone to bacterial infections, often by Candida and
filamentous fungi.
19. Disorder
Inheritance
Clinical Features
1) Chronic
granulomatous
disease
X-linked (66%);
autosomal
recessive (33%)
Infections with catalase producing bacteria
and fungi affecting skin, lungs, liver;
granuloma formation
2)Myeloperoxidase
deficiency
Autosomal
Recessive
Fungal infections (candidiasis) in deep tissues,
especially in presence of diabetes
3)Leukocyte
adhesion
deficiency
Auto-somal
recessive
Delayed separation of the umbilical cord; skin
infections; otitis media; pneumonia; gingivitis;
periodontitis
4)Abnormal
chemotaxis
-Hyper IgE
-chediak-Higashi
Variable
Recurrent skin infections with staphylococci.
enteric bacteria, Neuropathy, Occulocultaneous albinism in chediak higashi
22. EVALUATION OF IMMUNODEFICIENCY
Often present
Usually present
1. Recurrent respiratory
tract infections
2. Severe bacterial
infections
3. Recurrence of same
type of bacteria
4. Paucity of lymph nodes
and tonsils
1. Persistent sinusitis or
mastoiditis
2. Failure to thrive
3. Intermittent fever
4. Skin lesions
5. Diarrhea
6. Hearing loss due to chronic
middle ear infections
7. Chronic conjunctivitis
8. Bronchiectasis
9. Evidence of autoimmunity
10. Hematologic abnormality
Occasionally present
1.
2.
3.
4.
5.
6.
Lymphadenopathy
Hepatosplenomegaly
Severe viral illnesses
Chronic encephalitis
Deep infections
Delayed umbilical
detachment
7. Adverse reactions to
vaccines
24. Characteristic
T- cell defect
B- cell defect
Granulocyte defect
Complement defect
Age of onset of
infection
Early; 2-6 months
After 5-7 months
Early onset at birth
Any age
Specific pathogens
Mycobacteria,
Viruses, Fungus like
Candida and
parasites
Pyogenic bacteria
mainly Streptococci,
Staphylococci
Hemophilus
enteroviruses
Bacteria;
Staphylococcus
Pseudomonas
Klebsiella
Bacteria
Systemic effects
Failure to thrive,
Extensive
mucocutaneous
Candidiasis
Recurrent
sinopulmonary
infections
Malabsorption
Enteroviral
encephalitis
Skin abscesses,
impetigo, cellulitis
Recurrent
sinopulmonary
infections
Meningitis
Special features
GVHD, Post
vaccination
disseminated BCG or
Varicella
Hypocalcemic tetany
in infancy
Autoimmunity
Lymphoma
Thymoma
Post vaccination
paralytic polio
Prolonged
attachment of
umbilical cord
Poor wound healing
Autoimmune diseases
25. LABORATORY EVALUATION OF
IMMUNODEFICIENCY DISORDERS
• Routine investigations:
• Total and differential leucocyte counts
• Absolute lymphocyte count
• Normal result rules out T- cell defect
• Absolute neutrophil count
• Normal study rules out granulocyte defect
• Platelet count and morphology
• Normal result rules out WAS
• Howell- Jolly bodies
• ESR
26. Suspected B cell defect
Serum Electrophoresis
Hypogammaglobulinemia
Immunoglobulin pattern
B cell count
Low
XLA
Normal
Abnormal
Possible CVID
Normal
Consider complement or
phagocytic dysfunction
28. • Acquired immunodeficiency syndrome (AIDS) is a secondary
immunodeficiency
• AIDS is a disease caused by the retrovirus Human Immunodeficiency
Virus (HIV) which is a single stranded RNA virus
• It is characterized by profound immunosuppression that leads to
opportunistic infections, secondary neoplasms and neurologic
manifestations.
30. TRANSMISSION OF HIV INFECTION
• Sexual contact
• Most frequent mechanism
• 75-80% via unprotected sex
• The virus can pass from semen and vaginal secretions into the
bloodstream through mucous membranes and wounds in the skin.
• Blood-to-blood contact
• Needle stick injury
• Sharing of needles or
• Transfusion of blood and blood products.
31. • Perinatal transmission can occur in utero, during labor, or by breast
feeding
• Studies still show that HIV does not spread through casual contact or
by vectors such as mosquitoes
32. MAJOR ABNORMALITIES OF IMMUNE
FUNCTION IN AIDS
• Lymphopenia
• Predominantly due to selective loss of CD4+ helper inducer T cell
subset and reversal of CD4:CD8 ratio
• Decreased T cell function
• Preferential loss of memory T cells
• Susceptibility to opportunistic infections and neoplasms
• Decreased type IV hypersensitivity
33. • Polyclonal B cell activation
• Hypergammaglobulinemia and circulating immune complexes
• Altered monocyte and macrophage function
• Decreased chemotaxis
• Diminished antigen presenting to T cells.
35. CLINICAL MANIFESTATIONS OF
AIDS
• An infection by microorganism that normally does not cause disease
but become pathogenic when the body’s immune system is impaired
and unable to fight off the infection are “opportunistic infections”
(OIs).
• OIs are the hallmark of immunodeficiency with HIV
• It is important to diagnose OIs as the acute infections are at times lifethreatening and effective prophylaxis and treatment renders better
survival.
36. AIDS DEFINING OPPORTUNISTIC INFECTIONS
AND NEOPLASMS
• Infections:
• Protozoal and helminthic infections
•
•
•
•
Cryptosporidiosis or Isosporidiosis
Pneumoncystitis jirovecii pneumonia or disseminated infection
Toxoplasmosis
Strongyloidiasis
• Fungal infections
•
•
•
•
Candiadisis (esophageal, tracheal or pulmonary)
Cryptococcosis
Coccidioidomycosis
Invasive Aspergillosis
• Bacterial infections
• Mycobacteriosis (M. tuberculosis or atypical mycobacteriosis)
• Nocardiosis (Pneumonia, Meningitis or disseminated)
• Salmonellosis
37. • Viral infections
• Cytomegalovirus (pulmonary, intestinal, retinitis or CNS infection)
• Herpes- simplex virus and varicella – Zoster virus (localized or disseminated)
• Progressive multifocal leucoencephalopathy
• Neoplasms
•
•
•
•
Kaposi’s sarcoma
B cell non Hodgkin lymphoma
Primary lymphoma of brain
Invasive cancer of the cervix.
38. • There is a correlation between CD4 count and HIV related infections.
> 500 cells/mm3 – Recurrent vaginal candidiasis
200-500 cells/mm3 – Pulmonary TB, Pneumococcal pneumonia,
Herpes zoster, Oropharyngeal candidiasis, Recurrent Salmonellosis
< 200 cells/mm3 – Pneumocystis jirovecii pneumonia, mucocutaneous
Herpes simplex, Cryptosporidiosis, Esophageal candidiasis, Miliary/
Extrapulmonary TB.
< 100 cells/mm3 – cerebral Toxoplasmosis, Cryptococcal meningitis
< 50 cells/mm3 – CMV retinitis & gastrointestinal disease and
disseminated Mycobacterium avium intercellulare
40. • Tests to detect the presence of infection
• Detection of viral antigens in the serum
• Detection of antibodies to viral antigens in the serum
• Detection of viral genomic material in the blood
• Tests to determine the extent of the disease
• Total CD4+ helper T-cell count
• Quantitative viral RNA copies in blood.
• Tests to detect the presence of various opportunistic infections.
42. PRIMARY IMMUNODEFICIENCIES
• B cell deficiencies:
• IV Immunoglobulin 200-800mg/kg
• Culture and sensitivity of organisms causing infection
• Early drainage of abscess
• Early control of infection
• T cell deficiencies:
• Early treatment of infection
• Transplantation of foetal thymus or HLA matched bone marrow
• Topical and systemic antifungal therapy
• Stem cell transplantation is definitive therapy for SCID and most of
phagocytic disorders like LAD, CGD and Chediak- Higashi disease
43. • More recently Gene therapy has been attempted as an alternative to
the bone marrow transplant
• Transduction of the missing gene to hematopoietic stem cells
using viral vectors is being tested in ADA SCID and X-linked SCID
• In 1990, four-year-old Ashanthi DeSilva became the first patient to
undergo successful gene therapy. Researchers collected samples
of Ashanthi's blood, isolated some of her white blood cells, and
used a virus to insert a healthy adenosine deaminase (ADA) gene
into the defective cells.
• These cells were then injected back into her body, and began to
express a normal enzyme. This, augmented by weekly injections of
ADA, corrected her deficiency.
44. SECONDARY
IMMUNODEFICIENCIES
• Prompt and early instillation of anti retroviral therapy will help in control of the
disease
• Prophylaxis to prevent development of opportunistic infections.